Drop Down MenusCSS Drop Down MenuPure CSS Dropdown Menu

Try with us

Join & Get Updates

Friday, December 9, 2016

The production version of KTM RC16 MotoGP up for sale in 2018

KTM finally offer the production version motorcycle of RC16 MotoGP. But not for highway use, the replica was only offered as a track-only model for "Racing for Fun" customers. KTM calls it as the customer-spec models, and there are six variants to be made.
KTM RC16 MotoGP. (Picture from: http://adf.ly/1gU9x1)
KTM's CEO Stefan Pierer told a German media Speedweek, KTM being build at least 100 units of RC16 consumer-spec. And the company will make it as similar as possible to the MotoGP models.

The motorcycles will use a 90-degree V4 engine with a capacity of 1,000 cc, is the same as the MotoGP version. However, the consumer version was able to burst the power around 240 horsepower, slightly below the MotoGP version has the power up to 270 horsepower.
Rear side view of KTM RC16 MotoGP. (Picture from: http://adf.ly/1gU9x1)
Although it later became the most luxurious track-day motorcycle, KTM promised to try to suppress the price in order to remain affordable for consumers who want it. The model will be marketed in 2018 and claimed would be more cheaper than the production version of Honda RC213V-S has a price about US. $202,000 (or approx Rp.2.7 billion).
"I wish to offer the RC16 racer in a lower price than Honda's products. I think it cost about US. $104.74 thousand (or Rp.1.4 billion) to $127.18 thousand (or Rp.1.7 billion) alone." Pierer promises.

Kept spur your adrenaline on the power of two-wheeled monster and stay alive with the true safety riding. God will forgive Your sins and so does the cops.... ••• [EKA | FROM VARIOUS SOURCES | DRIVE SPARK]
Note: This blog  can be accessed via your smart phone

Thursday, December 8, 2016

Volvo is preparing the world's longest bus

Try to imagine a bus with a length as the train running on asphalt is not on rails. Yes, in the near future, the bus will be realized. And this time, Volvo is making an extremely large articulated bus to be used in Brazil.

As quoted from Autoblog, the bus called 'Gran Artic 300' will use a biarticulated chassis capable of carrying as many as 300 passengers at a time. By that measure, Gran Artic will be crowned as the longest bus in the world.
This Volvo Gran Artic 300 bus can hold up to 300 passengers with a lenght of 30 meters. (Picture from: http://adf.ly/1gU51I)
Gran Artic is designed for use in urban areas. Therefore, Volvo as much as possible not to impose the dimensions of Gran Artic too large, only with the length of approximately 30 meters.

In addition, Volvo also makes buses with a smaller size, named Artic, with a length of 20-23 meters. This bus has a capacity of between 150 to 180 passengers. Another Super Artic buses with a capacity of 30 passengers more than the Artic.
Left side view of Volvo Gran Artic 300 bus. (Picture from: http://adf.ly/1gU5bh)
Biarticulated chassis of Volvo Gran Artic 300 bus. (Picture from: http://adf.ly/1gU5bh)
Volvo makes Gran Artic 300 to meet orders from Bus Rapid Transitional Brazil. And the operation of long-sized buses later aimed to reduce the number of public vehicles on the road which will eventually reduce emissions and traffic congestion as well. *** [EKA | FROM VARIOUS SOURCES | PAULTAN | AUTOBLOG]
Note: This blog  can be accessed via your smart phone

Neurologists have found a way to eliminate the phobia

Neuroscientists have found a way to eliminate the specific fear (phobia) of the brains of patients by using a combination of artificial intelligence (AI) and brain scanning technology. This technique is expected to change the lives of those who suffer from excruciating acute phobia.

The process is called Decoded Neurofeedback requires no conscious effort of the subjects to overcome their fears, but rely on identifying patterns of the brain associated with a certain fear, which then 'overwritten' by using a 'gift' system.
An extreme fear of spiders and other arachnids called Arachnophobia. (Picture from: http://adf.ly/1gTy0j)
Even better, the phobia is gone forever after treatment. The researchers also say the technique will be used to treat a condition of Post-Traumatic Stress Disorder (PTSD).

"When inducing phobia memories in the brain, we were able to develop a fast and accurate method to read by using AI algorithms," explains Ben Seymour one of the researchers from the University of Cambridge, England.

"The challenge then is how to find ways to reduce or remove the phobia memory, without ever consciously raise it up again."

On the study involving 17 participants, and the scientists sought to associate a memory that triggers fear, with a prize or something positive.
One of the brain scans mapped with AI. (Picture from: http://adf.ly/1gTxcu)
"As a result, the memory features that were previously set to predict a painful surprise, are now predicting something positive," said lead researcher Ai Koizumi of the Advanced Telecommunications Research Institute International in Kyoto, Japan.

In further tests, when participants are confronted with pictures that can trigger the phobia, scientists no longer find any signs of fear or increased activity in the amygdala (part of the brain that processes fear).

This treatment technique was in contrast to conventional medical therapy, which exposes the patient directly to the cause of their fear. And conventional therapy is often successful. After trying hard to face his fears, most people just get rid of phobias.

But this new technique offers a treatment process which is completely painless for the patient is not even aware that they was on fight against their phobia. *** [EKA | FROM VARIOUS SOURCES | SCIENCE ALERT]
Note: This blog  can be accessed via your smart phone

Scomadi continued to test their newest scooter prototype

British scooter company, Scomadi had introduced a classic-modern style scooter that uses an engine with a capacity of 400 cc. And the scooter prototype was introduced at the EICMA Show 2016, in Milan, some time ago.
A prototype of Scomadi's 400 cc engined scooter at the EICMA Show 2016. (Picture from: http://adf.ly/1gRsxk)
Its classic style seems inspired by the design of Lambretta scooters, while its engine seen similar to those used in the Suzuki Burgman. However, Scomadi will not market the nameless scooter in the near future. The company said the production model will be available in 2018.

"The latest model 400 will be available in 2018. The project is still ongoing with a prototype is created manually," Scomadi said in a statement, as cited again by Visordown.
Left side view of Scomadi's 400 cc engined scooter prototype. (Picture from: http://adf.ly/1gRsB3)
Its modeling process by using the Computer Aided Design (CAD) and now the testing is still in progress as a transition process of the prototype into mass production. And the testing procedures were also done to ensure that the scooter is in compliance with Euro4 emission rules..
Right side view of Scomadi's 400 cc engined scooter prototype. (Picture from: http://adf.ly/1gRsB3)
Scomadi itself is a joint venture of two renowned tuners, ie Frank Sanderson of Scooter Innovation Ltd and Paul Melici from PM Tuning. The company already has two classic scooter products namely Scooter TL50 and TL125. Both scooters are still use carburetor engines and newly met the Euro3 emission standards.

Kept spur your adrenaline on the power of two-wheeled monster and stay alive with the true safety riding. God will forgive Your sins and so does the cops.... ••• [EKA | FROM VARIOUS SOURCES | SCOMADI | VISORDOWN]
Note: This blog  can be accessed via your smart phone

Wednesday, December 7, 2016

The replacement candidate of McLaren 650S began to roam on the street

The British sports car manufacturer, McLaren seems to have prepared a replacement of their McLaren 650S which had just circulated for 2 years. This McLaren's 650S successor will arrive next year with even more extreme styling than that of the P1 hypercar.
Rear view of the replacement candidate of McLaren 650S known internally as P14. (Picture from: http://adf.ly/1gRjZk)
As we have noted, McLaren 650S itself initially was only the development model of the McLaren MP4-12C, which differ only 25 percent, but the company later decided not to continue the 12C.

Now, as reported by Autocar, the successor model of 650S, and known internally as 'P14,' seemly began to be tested on the streets of England after previously seen in southern Europe. (Jump to the article).
Is this the figure of the replacement candidate of McLaren 650S known internally as P14? (Picture from: http://adf.ly/1gXem8)
McLaren P14 is believed retains to carry a V8 turbo engine with a capacity of 3,800 cc similar engine of the 12C and 650S, yet imbued with hybrid features and more abundant power to rival the Ferrari 488 GTB.
The P14 will use McLaren’s carbonfibre tub (albeit in its latest form) and its power output believed will be more powerfull and exceed the 641 hp of the 650S. Most likely, its facial part will be more similar to the McLaren P1, but with more conventional lighting unit forms with extra-powerful LED.. *** [EKA | FROM VARIOUS SOURCES | AUTOCARS]
Note: This blog  can be accessed via your smart phone

The first HIV vaccine efficacy study is conducted in South Africa

The first HIV vaccine efficacy study that will last seven years to test whether the modification of the candidate vaccine can provide effective protection against the virus that causes AIDS started in South Africa, says the National Institutes of Health (NIH) on Monday, 28 November 2016.

The study is called HVTN 702 was intended to enroll approximately 5,400 men and women aged 18 to 35 who are sexually active, and make the largest and most sophisticated clinical trials of HIV vaccines place in South Africa, in which more than 1,000 people are infected with HIV every day.
A 3D look at the HIV virus. (Picture from: http://adf.ly/1gRfO1)
"When deployed together with our current weapons proven to prevent HIV, the vaccine is safe and effective could be the last nail in the coffin of HIV," said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, and the organizers of these clinical trials.

"Even a moderately effective vaccine would significantly reduce the burden of HIV disease from time to time in countries and populations with high HIV infection rates such as South Africa."

The experimental vaccine regimen tested in HVTN 702 is based on the vaccine investigated in RV144 clinical trials in Thailand, showed that the vaccine was 31.2 percent effective in preventing infection during 3.5 years after vaccination.

The new vaccine regimen was adjusted to a prominent HIV subtype in Southern Africa and small preliminary clinical trials involving 252 people showed that it was safe for the study participants and the impact on the immune response comparable to that reported in RV144.

The new clinical trial conducted at 15 sites across South Africa aims to test whether the vaccine will provide greater protection and more continuous than the RV144 regimen.

Volunteers will be randomly be given the vaccine regimen that is still in the research or placebo. All participants will receive a total of five injections over a year and the results will be known late in 2020.

"HIV has claimed many deaths in South Africa, but now we begin scientific exploration could be very promising for our country," said Head of HVTN 702 Protocol Glenda Gray, who's also the president and chief executive of the Medical Research Council of South Africa.

"If the HIV vaccine successful in South Africa, it would dramatically change the course of the pandemic," she said as quoted by Xinhua news agency.. *** [EKA | FROM VARIOUS SOURCES | NIAID | LIVESCIENCE | XINHUA NEWS]
Note: This blog can be accessed via your smart phone.